Catalyst Wire Dossier Catalyst Wire Dossier

PLD

pegylated liposomal doxorubicin
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PLD, covering 2021-07-30 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1) [Phase 2, Phase 3]

See pricing